Stephen M Welcker, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 400 Russell Ave Bldg 41, Belle Chasse, LA 70037 Phone: 504-678-7970 |
Belle Chasse Optical Optometrist Medicare: Medicare Enrolled Practice Location: 102 Woodland Hwy, Ste 10, Belle Chasse, LA 70037 Phone: 504-393-0002 Fax: 504-392-0770 |
Thuy Thanh Nguyen, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 102 Woodland Hwy Ste 10, Belle Chasse, LA 70037 Phone: 504-393-0002 Fax: 504-392-0770 |
News Archive
With the warmer weather and longer days starting to settle in, that can only mean one thing: time to break out of the winter hibernation mode, bust out the summer wardrobe and get out there! And no matter what the occasion or setting, Black is Back™ with PG Tips Black Tea, a refreshing, revitalizing and forward-thinking interpretation of a cultural classic.
New research at the University of Adelaide has shed light on how many doctors are attending the funerals of their patients and the reasons behind their choice. The researchers say more needs to be done within the medical profession to openly discuss the issue.
Caris Life Sciences and investigators from Inova Fairfax Hospital presented the first clinical outcomes data presentation from the Caris Registry™ at the 50th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Ill., this weekend.
"Dilma Rousseff had barely been confirmed as Brazil's new president in November when she made her first foreign visit, to Mozambique," which "included a symbolic stop-off at a pharmaceutical factory that is under construction in preparation for opening in 2014. … The plant will produce a range of medicines for one of its leading lusophone - Portuguese-speaking - African partners, marking the resurgent power and growing reach of its sponsor, Brazil's own state-led drug sector," the Financial Times writes in an article that examines the partnerships Brazil is establishing at home and abroad.
The combination drug valsartan/sacubitril known as LCZ696 significantly reduced aortic systolic blood pressure and pulse pressure compared to the standard angiotensin receptor blocker (ARB) olmesartan in patients with hypertension, according to results of the PARAMETER study.
› Verified 9 days ago